Oceans Healthcare has announced the addition of highly regarded Harvard Medical School psychiatry professor Dr. Michael Jellinek and decorated public health executive Dr. Courtney Phillips to its Board of Directors. These additions underscore the growing behavioral health organization’s commitment to advancing healing and long-term recovery through patient-centered behavioral health care. “Our nation’s behavioral health crisis demands […]
Amazon Spring Sale 2024: Save 15% to 40% on Jackery Mini Power Stations, Solar Generators, and More
Just in time for the start of the outdoor season, Jackery is offering deep discounts on selected power stations and solar generators via Amazon. Suitable for canny savers and Easter Bunnies alike, the high-quality portable power solutions are available at heavily discounted prices from 20 to 25 March 2024 in the Jackery UK Amazon shop. […]
New Knee Research Finds Exactech Technologies Improve Patient Outcomes
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced new research that reports surgeons using ExactechGPS® guided personalized surgery and its Newton® ligament-driven balancing technique experience clinically significant improvements on postoperative Knee Society Knee and Function scores when compared to traditional navigated gap […]
Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
Venus Remedies, one of India’s leading exporters of generic medicines in critical care segments, has further expanded the reach of its oncology drugs in the Asia Commonwealth of Independent States (CIS) region with marketing authorisations from Ukraine for three cancer drugs, including paclitaxel, oxaliplatin and irinotecan.With revenues projected to grow […]
Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure
CSL Vifor today announced that Health Canada has authorized Ferinject (ferric carboxymaltose) for the intravenous (IV) treatment of iron deficiency anemia in adult and pediatric patients one year of age and older when oral iron preparations are not tolerated or are ineffective, as well as for the treatment of iron deficiency in […]
Tetra Pharm Technologies introduces pain relieving drug in the United Kingdom
Following last year’s successful launch of XATEPA® in Germany, the cannabinoid-based product will now become available to patients in the United Kingdom during Q2 2024. XATEPA® is a carefully formulated drug designed to provide effective relief from chronic pain as well as discomfort arising from MS spasms and nausea. The innovative sublingual spray is […]
Samsung Medison and Bracco Imaging Forge Path with New Diagnostic Ultrasound Technology Agreement at ECR 2024
Samsung Medison (CEO, Mr. Yongkwan Kim) and Bracco Imaging (CEO, Dr. Fulvio Renoldi Bracco) endorsed a Memorandum of Understanding (hereinafter “MoU”) agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 (hereinafter “ECR 2024”) held in Vienna, Austria on February 28th to March 3rd. The […]
Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation, Philips’ extensive global R&D programs and collaborations position the company at the forefront of […]
Prof. Raj Kumar of Vallabhbhai Patel Chest Institute Selected for ATS Public Service Award by American Thoracic Society
The American Thoracic Society (ATS) Awards Committee has selected Prof. Raj Kumar, Director of Vallabhbhai Patel Chest Institute (VPCI) for the annual ATS Public Service Award at the ATS 2024 International Conference in San Diego, California. This public service award is given to individuals in the areas related to public […]
Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and psychiatric disorders, including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia, and other central nervous system (CNS) diseases, today announced that the first patient in its U.S. […]
